Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Prostate Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    August 2025
  1. ABREU-GOMEZ J
    Artificial Intelligence-Assisted MRI Interpretation in Prostate Cancer: Supporting Confidence and Reducing Variability.
    AJR Am J Roentgenol. 2025 Aug 6. doi: 10.2214/AJR.25.33622.
    PubMed    


    July 2025
  2. TIRUMANI SH
    Beyond the AJR: MRI-Directed Pathway Is the Preferred Strategy for the Workup of Suspected Prostate Cancer.
    AJR Am J Roentgenol. 2025 Jul 2. doi: 10.2214/AJR.25.33434.
    PubMed    


    March 2025
  3. SPILSETH B
    Moving Towards Widespread Adoption of Prostate Cancer Screening With MRI: Questions Remaining for Optimization.
    AJR Am J Roentgenol. 2025 Mar 12. doi: 10.2214/AJR.25.32892.
    PubMed    


  4. SALINAS-MIRANDA E, Birosh A, Mcinnes MDF, Breau RH, et al
    NPV of Biparametric and Multiparametric Prostate MRI: A Comparative Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2025 Mar 5. doi: 10.2214/AJR.24.32328.
    PubMed     Abstract available


    February 2025
  5. SCHOOTS IG, Haider MA, Punwani S, Padhani AR, et al
    MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening.
    AJR Am J Roentgenol. 2025 Feb 19. doi: 10.2214/AJR.24.32588.
    PubMed     Abstract available


    December 2024
  6. LEWIS S, Rastinehad AR
    Beyond the AJR: Prostate Cancer Screening-Safe Omission of Biopsy in Patients With Negative MRI and the Need for High-Quality Imaging Standards.
    AJR Am J Roentgenol. 2024 Dec 11. doi: 10.2214/AJR.24.32431.
    PubMed    


    October 2024
  7. MARGOLIS DJA, Chatterjee A, deSouza NM, Fedorov A, et al
    Quantitative Prostate MRI, From the AJR Special Series on Quantitative Imaging.
    AJR Am J Roentgenol. 2024 Oct 2. doi: 10.2214/AJR.24.31715.
    PubMed     Abstract available


    May 2024
  8. SAVIR-BARUCH B, Parent E
    Beyond the AJR: PET/MRI Using (68)Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment.
    AJR Am J Roentgenol. 2024 May 15. doi: 10.2214/AJR.24.31412.
    PubMed    


    April 2024
  9. DIAS AB, Chang SD, Fennessy FM, Ghafoor S, et al
    New Prostate MRI Scoring Systems (PI-QUAL, PRECISE, PI-RR, and PI-FAB): AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.30956.
    PubMed     Abstract available


    March 2024
  10. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence".
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31168.
    PubMed    


  11. TAKAHASHI T
    Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence.
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31070.
    PubMed    


  12. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    Reply to "Is PI-RADS Ready for Biparametric Prostate MRI?".
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31169.
    PubMed    


  13. DANA J, Reinhold C, Gauvin S
    Is PI-RADS Ready for Biparametric Prostate MRI?
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31094.
    PubMed    


    February 2024
  14. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    PubMed     Abstract available


    January 2024
  15. LAWRENCE EM
    Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version 2.0 and Version 2.1.
    AJR Am J Roentgenol. 2024;222:e2330325.
    PubMed    


    December 2023
  16. BIROSH A, Miranda ES, Breau RH, McInnes MDF, et al
    Multiparametric Versus Biparametric Prostate MRI: Comparison of NPV for Clinically Significant Prostate Cancer.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30496.
    PubMed    


    October 2023
  17. THAMPY R, Spilseth B
    Beyond the AJR: Increased Use of Prostate MRI Before Biopsy Reduces Biopsy Frequency Without Compromising Detection of Aggressive Cancer.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.30407.
    PubMed    


  18. TAN N, Pollock JR, Margolis DJA, Padhani AR, et al
    Management of Patients With a Negative Multiparametric Prostate MRI Examination: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.29969.
    PubMed     Abstract available


    September 2023
  19. YILMAZ EC, Lin Y, Belue MJ, Harmon SA, et al
    PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29964.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.